NCT05852990View on ClinicalTrials.gov

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

PHASE3RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 12, 2025

Conditions
Non-Small Cell Lung Cancer With EGFR Mutation
Interventions
COMBINATION_PRODUCT

Glutamine plus L. reuteri

Glutamine plus Lactobacillus reueri twice daily for up to 6 weeks or death

Trial Locations (1)

14080

RECRUITING

Instituto Nacional de Cancerologia de Mexico, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cancerologia de Mexico

OTHER